(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AXIOMER

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

AXIOMER

ST13

US500000079192823

Class

1, 5, 42

Filing

79192823

Registration

5229979

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

10/07/2024

Trademark type

Combined

Nice classes

1, 5, 42

Filing date

03/23/2016

Registration date

06/27/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/12/2024

Last transaction

01/12/2024

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

NL

Examiner

EVANKO, PATRICIA MALESARDI

Law office

N10

Current location

TMO LAW OFFICE 119

Holders and representatives

Holders

ProQR Therapeutics II B.V.

Representatives

Krista Weber Powell TRASKBRITT, P.C.

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical compounds for scientific or research purposes

Class 5

Pharmaceutical preparations for the treatmentdiagnosis and prevention of genetic diseases and disorders; pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotidesoligoribonucleotidesaptamersnucleic acid moleculesdna* for use in * rnapolynucleotidesribozymesmirnassnornasmrnas or sirnas

Class 42

Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; laboratory research and analysis in the field of medicines; services of biotechnologicalchemical and pharmacological laboratoriesincluding scientific and technological researchin relation to the production of chemicals and biotechnological products for use in the preparation of pharmaceuticals; development of pharmaceutical preparations and medicines; development of technologies for the production of pharmaceutical semi finished and/or finished preparations; academic researchmedical and biochemical research and development services; chemistrylaboratory technicians' and engineering services; research and development in the field of biotechnology; research into and development and testing of pharmaceutical and biochemical semi- finished productsin particular for use in medicinesresearch into and development and testing of medicines; development of test systems for pharmaceuticalmedical and sanitizing preparations; services development and identification of and research into new drug targets

Publications

History of USPTO decisions and trademark events.

36 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

10/07/2024

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

09/14/2024

INPC

INVALIDATION PROCESSED

09/14/2024

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

09/13/2024

C71T

CANCELLED SECTION 71

01/12/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/27/2022

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

04/12/2018

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

04/08/2018

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/28/2017

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/28/2017

FIMP

FINAL DISPOSITION PROCESSED

09/28/2017

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/27/2017

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

08/08/2017

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

08/08/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/08/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

06/27/2017

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

06/23/2017

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

05/24/2017

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

04/20/2017

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

02/06/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/10/2017

PUBO

PUBLISHED FOR OPPOSITION

01/10/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/21/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/02/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/01/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/01/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/01/2016

RFNT

REFUSAL PROCESSED BY IB

11/11/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/27/2016

RFRR

REFUSAL PROCESSED BY MPU

10/27/2016

MAFR

APPLICATION FILING RECEIPT MAILED

10/11/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/07/2016

CNRT

NON-FINAL ACTION WRITTEN

10/06/2016

DOCK

ASSIGNED TO EXAMINER

10/06/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/06/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/01/2016

Continuous trademark protection

Get notified about every new filing that threatens AXIOMER or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.